Prosecution Insights
Last updated: May 29, 2026

Wayne State University

18 pending office actions • 17 art units • 18 examiners • 0 of 18 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Portfolio Summary

18
Total Pending OAs
13
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
1
Due this week
4
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 7 days (1)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (6%)
14
Medium (78%)
1
Easy (6%)
2
Unknown (11%)

Rejection Statute Mix

BucketCases
§101 only1 (6%)
§103 only14 (78%)
§112 only1 (6%)
No statute on record2 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
6% of docket
5
Mechanical / Eng
28% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

180 h
Manual time on pending OAs
36 h
Time saved (low, 20%)
63 h
Time saved (mid, 35%)
1.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHANG, LEI 1 0.0% +0.0%
PHAM, KATHERINE-PH MINH 1 53.6% +56.7%
HAN, SETH 1 60.0% +24.8%
RHOADES, DEREK JAMES 1 73.8% +23.0%
STEPHENS, AMELIA CAROLE 1 50.0% +100.0%
BUGG, PAIGE KATHLEEN 1 58.0% +59.9%
WASHVILLE, JEFFREY D 1 79.9% -4.8%
SHOMER, ISAAC 1 63.1% +30.7%
WOOLWINE, SAMUEL C 1 61.0% +20.0%
COOK, CHRISTOPHER L 1 46.8% +27.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17862825 METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR CHANDRA, GYAN 44d overdue
18858953 METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS ZHANG, LEI 69d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18144382 IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA SHOMER, ISAAC 91d overdue
18308611 REVERSE TRANSCRIPTION-FREE QUANTITATIVE-DISCRETE POLYMERASE CHAIN REACTION FOR POST-PROCESS QUALITY CONTROL OF VESICULAR BIOLOGICS WOOLWINE, SAMUEL C 53d overdue
18436626 COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY FACTORS FOR TREATMENT OF CANCER RHOADES, DEREK JAMES 46d overdue
18690227 VENTRICULAR CATHETERS AND OTHER EMBODIMENTS HAN, SETH 24d overdue
18400897 TRANSKETOLASE EPITOPES, METHODS, AND DEVICES FOR IGG-BASED TUBERCULOSIS SERODIAGNOSIS STEPHENS, AMELIA CAROLE 3d overdue
18036789 PERSONAL ULTRAVIOLET RESPIRATORY GERM ELIMINATION MACHINE (PUR GEM) BUGG, PAIGE KATHLEEN 9d
18690225 SOLID STATE SHUNT VALVE WITH ACTIVE OUTFLOW REGULATOR, VENTRICULAR CATHETERS, AND OTHER EMBODIMENTS PHAM, KATHERINE-PH MINH 27d
18028150 SYSTEMS AND METHODS FOR PREDICTING AND PREVENTING BLEEDING AND OTHER ADVERSE EVENTS COOK, CHRISTOPHER L 53d

Top Art Units

Art UnitApps
3781 2
3798 1
1692 1
1645 1
3785 1
1766 1
1612 1
1681 1
3797 1
1795 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18858953 METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS ZHANG, LEI 3798 §103 Final Rejection 69d Pending Oct 22, 2024
18690225 SOLID STATE SHUNT VALVE WITH ACTIVE OUTFLOW REGULATOR, VENTRICULAR CATHETERS, AND OTHER EMBODIMENTS PHAM, KATHERINE-PH MINH 3781 §103 Non-Final OA 27d Pending Mar 07, 2024
18690227 VENTRICULAR CATHETERS AND OTHER EMBODIMENTS HAN, SETH 3781 §103 Non-Final OA 24d overdue Pending Mar 07, 2024
18436626 COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY FACTORS FOR TREATMENT OF CANCER RHOADES, DEREK JAMES 1692 Other Non-Final OA 46d overdue Pending Feb 08, 2024
18400897 TRANSKETOLASE EPITOPES, METHODS, AND DEVICES FOR IGG-BASED TUBERCULOSIS SERODIAGNOSIS STEPHENS, AMELIA CAROLE 1645 §103 Non-Final OA 3d overdue Pending Dec 29, 2023
18036789 PERSONAL ULTRAVIOLET RESPIRATORY GERM ELIMINATION MACHINE (PUR GEM) BUGG, PAIGE KATHLEEN 3785 §103 Non-Final OA 9d Pending May 12, 2023
18252416 COMPOSITIONS AND METHODS FOR INHIBITION OF TISSUE ADHESION WASHVILLE, JEFFREY D 1766 §103 Non-Final OA 84d Pending May 10, 2023
18144382 IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA SHOMER, ISAAC 1612 §103 Non-Final OA 91d overdue Pending May 08, 2023
18308611 REVERSE TRANSCRIPTION-FREE QUANTITATIVE-DISCRETE POLYMERASE CHAIN REACTION FOR POST-PROCESS QUALITY CONTROL OF VESICULAR BIOLOGICS WOOLWINE, SAMUEL C 1681 §112 Non-Final OA 53d overdue Pending Apr 27, 2023
18028150 SYSTEMS AND METHODS FOR PREDICTING AND PREVENTING BLEEDING AND OTHER ADVERSE EVENTS COOK, CHRISTOPHER L 3797 §103 Final Rejection 53d Pending Mar 23, 2023
18165890 INLINE ENRICHMENT AND SEPARATION OF BIOMOLECULES IN MICROFLUIDIC DEVICES GAMBLE JR, RANDALL LEE 1795 §103 Final Rejection 88d overdue Pending Feb 07, 2023
18100800 MOLYBDENUM-DAD PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS TUROCY, DAVID P 1718 §103 Final Rejection 8d Pending Jan 24, 2023
18061323 HEPARANASE INHIBITORS FOR TREATMENT OF DIABETES CHO, DAVID H 1693 Other Final Rejection 80d overdue Pending Dec 02, 2022
17970758 SYSTEM AND METHOD FOR PREDICTING MACHINE FAILURE NYAMOGO, JOSEPH A 2858 §103 Non-Final OA 6d Pending Oct 21, 2022
18045126 DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS MARTIN, PAUL C 1653 §103 Non-Final OA 91d overdue Pending Oct 07, 2022
17862825 METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR CHANDRA, GYAN 1674 §101 Non-Final OA 44d overdue Pending Jul 12, 2022
17636107 IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 YOUNG, MICAH PAUL 1618 §103 Non-Final OA 12d Pending Feb 17, 2022
17434692 INDUCTION OF HIGHLY EFFICACIOUS ANTI-TUMOR AND IMMUNE MODULATING ACTIVITY: CELL-FREE OFF THE SHELF THERAPEUTIC MODALITY BUTTICE, AUDREY L 1647 §103 Non-Final OA 34d Pending Aug 27, 2021

Managing Wayne State University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month